Breaking News

Biocytogen Pharmaceuticals Beijing Co Ltd (2315)

Hong Kong

Add to/Remove from a Portfolio Add to Watchlist

9.57 +0.37 +4.02%

07:15:00 - Delayed Data. Currency in HKD ( Disclaimer )

Type: Equity

Market: Hong Kong

ISIN: CNE100005D27

Volume: 115,500
Bid/Ask: 9.22 / 10.58
Day's Range: 8.84 - 9.57

General
Chart
- Streaming charts
- Interactive Chart
Financials
Technical
Forum

Biocytogen Pharmaceuticals Beijing Co Ltd Company Profile

Get an in-depth profile of Biocytogen Pharmaceuticals Beijing Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

1066

Equity Type

ORD

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of antibody-based drugs in the People’s Republic of China, the United States, and internationally. Its core products are YH001, a recombinant humanized anti-cytotoxic t-lymphocyte associated protein 4 immunoglobulin G1 (IgG1) monoclonal antibody, which has completed Phase I clinical trial for the treatment of patients with advanced solid tumors; and YH003, a humanized IgG2 agonistic monoclonal antibody that is in Phase II clinical trial for the treatment of unresectable/metastatic mucosal melanoma and pancreatic duct adenocarcinoma, and Phase I clinical trial for the treatment of solid tumors. The company also develops YH002, a recombinant humanized IgG1 antibody that targets the human tumor necrosis factor receptor superfamily, member 4 receptor, which is Phase I clinical trial; YH004, a humanized anti-4- tumor necrosis factor receptor superfamily, member 9 IgG1 antibody that is in Phase I clinical trial for the treatment of advanced solid tumors and relapsed/refractory non-Hodgkin’s lymphoma; and YH008, an anti-PD-1 x cluster of differentiation 40 (CD40) bispecific antibody that is in Phase I clinical trial for the treatment of solid tumors. In addition, its preclinical candidates include YH012 and YH013, fully human anti-HER2/TROP2 bispecific antibody drugs conjugate for therapeutic product development, manufacturing, and commercialization for all human indications; YH015, a fully human IgG1 antagonistic monoclonal antibody targeting CD40; and YH016 and YH017, two novel molecules. The company has collaboration with Syncromune, Inc.; out license agreement with RemeGen Co., Ltd.; and license agreement with Chipscreen NewWay Biosciences. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. was incorporated in 2009 and is headquartered in Beijing, China.

Contact Information

Address 12 Baoshen South Street Daxing Bio-Medicine Industry Park
Daxing District Beijing,
China

Phone 86 10 5696 7680

Fax -

Web biocytogen.com.cn

Top Executives

Name	Age	Since	Title
Kexiang Zhou	59	2018	Non-Executive Director
Fengmao Hua	54	2021	Independent Non-Executive Director
Xiaoyan Liang	56	2020	Independent Non-Executive Director
Changyuan Yu	60	2020	Independent Non-Executive Director
Yiliang Wei	52	2015	Non-Executive Director
Jiawei Yao	40	2022	Supervisor
Jian Ni	52	2009	Executive Director
Haichao Zhang	42	2019	Senior Operation Director of Animal Center & Executive Director
Leidi Zhang	43	2022	Non-Executive Director
Yan Li	35	2015	Chairman of the Supervisory Committee & Director of the President’s Office
Chunli Sun	44	2020	Director of Human Resources & Supervisor

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

2315 Comments

Write your thoughts about Biocytogen Pharmaceuticals Beijing Co Ltd

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	3,635.91	+29.83	+0.83%
NSE All Share	98,156.71	+770.09	+0.79%
US 30	39,885.4	+16.0	+0.04%
US 500	5,301.3	+4.2	+0.08%
FTSE 100	8,438.65	-7.15	-0.08%
DAX	18,725.71	-143.65	-0.76%
South Africa Top 40	73,214.00	+71.84	+0.10%

Brent Oil	83.78	+0.51	+0.61%
Crude Oil WTI	79.56	+0.33	+0.42%
Gold	2,389.80	+4.30	+0.18%
Silver	29.915	+0.039	+0.13%
Copper	4.9618	+0.0815	+1.67%
London Cocoa	6,240.00	0.00	0.00%
London Wheat	187.30	-7.00	-3.60%

Nigeria 10Y	19.316	+0.005	+0.00%
Nigeria 2Y	19.266	+0.050	+0.00%
U.K. 10Y	4.1070	+0.0250	+0.61%
Germany 10Y	2.4625	+0.0185	+0.76%
U.S. 10Y	4.371	-0.004	-0.09%
U.S. 5Y	4.396	-0.003	-0.08%
U.S. 2Y	4.784	-0.007	-0.14%

Access Bank	10.00	+0.00	+0.00%
Zenith Bank	32.50	-0.80	-2.40%
UBA	20.95	-1.10	-5.00%
FBN Holdings	22.00	-1.30	-5.36%
Guaranty Trust Holding	39.60	-2.25	-5.33%
Sterling Bank	4.080	+0.190	+4.74%
Dangote Cement	591.10	-65.60	-9.99%

Recent Quotes

Name	Price	Chg.	Chg. %
2315	9.57	+0.37	+4.02%
STOR	3.630	0.000	0.00%
INV	0.140	0.000	0.00%
INVS	117	0	0.00%
KraneShares FTSE .	25.35	0.00	0.00%
TEMB	237.20	-2.85	-1.19%
MUKAM MUFJ Emergi.	1,271.930	-0.070	-0.01%
Sanlam Alternativ.	1.000	0.000	0%

Market Movers

Name	Last	Chg. %	Vol.
Nigerian Breweries	22.85	+1.77%	83.69M
UBA	20.95	-5.00%	26.03M
Access Holdings	16.80	-1.45%	24.15M
Guaranty Trust Holding	39.60	-5.33%	22.93M
Zenith Bank	32.50	-2.40%	10.65M
Airtel Africa	2,150.00	+8.97%	1.01M
MTN Nigeria	224.00	0.00%	787.37K

Name	Last	Chg. %	Vol.
Royalex	0.55	+10.00%	8.02M
Guinea Insurance PLC	0.33	+10.00%	2.24M
McNichols	1.10	+10.00%	123.56K
Total Nig	353.60	+9.98%	13.01K
Abbey Mortgage Bank	2.69	+9.35%	1.13K
Berger Paints	13.50	+9.31%	16.66K
University Pre	2.350	+9.30%	172.26K

Name	Last	Chg. %	Vol.
Mrs	121.50	-10.00%	5.82K
Transcorp Hotels	91.71	-10.00%	2.37K
Geregu Power	900.00	-10.00%	0.28K
Dangote Cement	591.10	-9.99%	3.53K
BUA Cement	128.90	-9.99%	23.40K
Mecure Industries	8.75	-9.98%	0.03K
ETI	21.65	-9.98%	7.03K